Article info

Download PDFPDF

Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab

Authors

  1. Correspondence to Dr Shigehira Saji; ss-saji{at}wa2.so-net.ne.jp
View Full Text

Citation

Natori Y, Sasaki E, Soeda S, et al
Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab

Publication history

  • Accepted August 23, 2020
  • First published October 1, 2020.
Online issue publication 
October 01, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.